prikaz prve stranice dokumenta Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids
Access restricted to students and staff of home institution
Scientific paper - Original scientific paper
Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids
Current Vascular Pharmacology, 17 (2019), 5; 507-516. https://doi.org/10.2174/1570161117666190705141152
M’baya-Moutoula, Eleonore; Marchand, Alexandre; Six, Isabelle; Bahrar, Noura; Ćelić, Tanja; Mougenot, Nathalie; Maitrias, Pierre; Massy, Ziad A.; Lompreh, Anne-Marie; Metzinger, Laurent; Meuth, Valérie Metzinger-Le

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

M’baya Moutoula, E., Marchand, A., Six, I., Bahrar, N., Ćelić, T., Mougenot, N. ... Meuth, V. M. L. (2019). Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids. Current Vascular Pharmacology, 17. (5), 507-516. doi: 10.2174/1570161117666190705141152

M’baya Moutoula, Eleonore, et al. "Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids." Current Vascular Pharmacology, vol. 17, no. 5, 2019, pp. 507-516. https://doi.org/10.2174/1570161117666190705141152

M’baya Moutoula, Eleonore, Alexandre Marchand, Isabelle Six, Noura Bahrar, Tanja Ćelić, Nathalie Mougenot, Pierre Maitrias, et al. "Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids." Current Vascular Pharmacology 17, no. 5 (2019): 507-516. https://doi.org/10.2174/1570161117666190705141152

M’baya Moutoula, E., et al. (2019) 'Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids', Current Vascular Pharmacology, 17(5), pp. 507-516. doi: 10.2174/1570161117666190705141152

M’baya Moutoula E, Marchand A, Six I, Bahrar N, Ćelić T, Mougenot N, and sur.. Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids. Current Vascular Pharmacology [Internet]. 2019 [cited 2024 May 13];17(5):507-516. doi: 10.2174/1570161117666190705141152

E. M’baya Moutoula, et al., "Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids", Current Vascular Pharmacology, vol. 17, no. 5, pp. 507-516, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:088359. [Accessed: 13 May 2024]

Metadata
Title (english)Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids
AuthorEleonore M’baya-Moutoula
AuthorAlexandre Marchand
AuthorIsabelle Six
AuthorNoura Bahrar
AuthorTanja Ćelić
AuthorNathalie Mougenot
AuthorPierre Maitrias
AuthorZiad A. Massy
AuthorAnne-Marie Lompreh
AuthorLaurent Metzinger
AuthorValérie Metzinger-Le Meuth
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Anatomy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Basic Medical Sciences
Anatomy
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Surgery
Abstract (english)
Objective: Restenosis is a frequent complication of angioplasty. It consists of a neointimal hyperplasia resulting from progression and migration of vascular smooth muscle cells (VSMC) into the vessel lumen. microRNA miR-223 has recently been shown to be involved in cardiovascular diseases including atherosclerosis, vascular calcification and arterial thrombosis. In this study, our aim was to assess the impact of miR-223 modulation on restenosis in a rat model of carotid artery after balloon injury. Methods: The over and down-expression of miR-223 was induced by adenoviral vectors, containing either a pre-miR-223 sequence allowing artificial miR-223 expression or a sponge sequence, trapping the native microRNA, respectively. Restenosis was quantified on stained rat carotid sections. Results: In vitro, three mRNA (Myocyte Enhancer Factor 2C (MEF2C), Ras homolog gene family, member B (RhoB) and Nuclear factor 1 A-type (NFIA)) reported as miR-223 direct targets and known to be implicated in VSMC differentiation and contractility were studied by RT-qPCR. Our findings showed that down-expression of miR-223 significantly reduced neointimal hyperplasia by 44% in carotids, and was associated with a 2-3- fold overexpression of MEF2C, RhoB and NFIA in a murine monocyte macrophage cell line, RAW 264.7 cells. Conclusion: Down-regulating miR-223 could be a potential therapeutic approach to prevent restenosis after angioplasty.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleCurrent Vascular Pharmacology
Numberingvol. 17, no. 5, pp. 507-516
p-ISSN1570-1611
DOIhttps://doi.org/10.2174/1570161117666190705141152
URN:NBNurn:nbn:hr:184:088359
Publication2019
Document URLhttp://bib.irb.hr/1053178
Type of resourceText
Access conditionsInstitutional access
Terms of useLicence In copyright icon
Created on2022-03-15 08:25:32